MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, MIRM made $521,312K in revenue. -$23,363K in net income. Net profit margin of -4.48%.

Income Overview

Revenue
$521,312K
Net Income
-$23,363K
Net Profit Margin
-4.48%
EPS
-$0.47
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • Non Us
Revenue Breakdown
    • Livmarli
    • Bile Acid Medicines
Revenue Breakdown
    • US
    • Non Us
Revenue Breakdown
    • Research and development expense...
    • Commercialization and medical af...
    • Cost of sales (excluding intangi...
    • Others

Income Statement
2025-12-31
Total revenue
521,312
Cost of sales
100,240
Research and development
186,178
Selling, general and administrative
257,030
Total operating expenses
543,448
Loss from operations
-22,136
Interest income
12,727
Interest expense
14,389
Loss from termination of revenue interest purchase agreement
0
Other income (expense), net
2,371
Loss before provision for income taxes
-21,427
Provision for income taxes
1,936
Net loss
-23,363
Basic EPS
-0.47
Diluted EPS
-0.47
Basic Average Shares
50,198,304
Diluted Average Shares
50,198,304
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$23,363K US$401,547K Non Us$119,765K Loss beforeprovision for income taxes-$21,427K Provision for income taxes$1,936K Interest income$12,727K Product$521,312K Other income(expense), net$2,371K Loss from operations-$22,136K Total revenue$521,312K Interest expense$14,389K Total operatingexpenses$543,448K Selling, general andadministrative$257,030K Research and development$186,178K Cost of sales$100,240K

Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals, Inc. (MIRM)